Gilead Sciences (GILD)

63.19 +1.09 (1.76%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (10/26/20 *Est.)
- M&A (6/30/20 *Est)
- M&A (12/31/20 *Est)

Latest Headlines

Gilead Sciences (GILD) Presents Data From HIV Research and Development Programs at HIV Glasgow 2020 September 30, 2020 8:38 AM - StreetInsider Gilead Sciences Presents Data From HIV Research and Development Programs at HIV Glasgow 2020 September 30, 2020 8:37 AM - BizWire Form 8-K GILEAD SCIENCES INC For: Sep 30 September 30, 2020 8:20 AM - SEC Filing Jefferies Reinstates Gilead Sciences (GILD) at Buy September 30, 2020 12:26 AM - StreetInsider Form 8-K GILEAD SCIENCES INC For: Sep 23 September 29, 2020 4:22 PM - SEC Filing Form 424B5 GILEAD SCIENCES INC September 25, 2020 5:05 PM - SEC Filing Gilead Sciences (GILD), Galapagos NV (GLPG) Announce European Commission Grants Marketing Authorization for Jyseleca (Filgotinib) for Treatment of Adults with Moderate to Severe Active RA September 25, 2020 1:16 PM - StreetInsider European Commission Grants Marketing Authorization for Jyseleca® ▼ (Filgotinib) for the Treatment of Adults With Moderate to Severe Active Rheumatoid Arthritis September 25, 2020 1:00 PM - BizWire EUROPEAN  COMMISSION  GRANTS  MARKETING  AUTHORIZATION FOR JYSELECA® (FILGOTINIB)  FOR  THE  TREATMENT  OF  ADULTS  WITH  MODERATE  TO  SEVERE ACTIVE  RHEUMATHOID  ARTHRITIS September 25, 2020 1:00 PM - StreetInsider Gilead Sciences (GILD), Galapagos NV (GLPG) Report Jyseleca (filgotinib) Approved in Japan for Rheumatoid Arthritis September 25, 2020 6:31 AM - StreetInsider Correction: Jyseleca® (filgotinib) approved in Japan for rheumatoid arthritis September 25, 2020 2:14 AM - StreetInsider Jyseleca® (filgotinib) approved in Japan for rheumatoid arthritis September 25, 2020 2:01 AM - StreetInsider Jyseleca® (Filgotinib) Approved in Japan for Rheumatoid Arthritis September 25, 2020 2:00 AM - BizWire Gilead Sciences (GILD) Prices $7.25 Billion of Senior Unsecured Notes September 24, 2020 6:24 AM - StreetInsider Gilead Sciences (GILD) Thoughts After KOL Call - RBC Capital September 24, 2020 6:11 AM - StreetInsider Form FWP GILEAD SCIENCES INC Filed by: GILEAD SCIENCES INC September 24, 2020 6:03 AM - SEC Filing Gilead Sciences Prices $7.25 Billion of Senior Unsecured Notes September 23, 2020 10:33 PM - BizWire Gilead (GILD) to Sell $7.25B of Bonds to Fund Immunomedics (IMMU) Deal - Bloomberg September 23, 2020 2:03 PM - StreetInsider Form 424B5 GILEAD SCIENCES INC September 23, 2020 9:10 AM - SEC Filing Canada at 'crossroads' as COVID-19 cases surge September 22, 2020 12:37 PM - StreetInsider Gilead Sciences (GILD) PT Raised to $86 at RBC Capital Ahead of ESMO Conference September 18, 2020 6:48 AM - StreetInsider Eli Lilly (LLY) Said Baricitinib in Combination with Remdesivir Reduces Time to Recovery in Hospitalized Patients with COVID-19 September 17, 2020 1:44 PM - StreetInsider Gilead Sciences (GILD) Receives FDA Breakthrough Therapy Designation for Treatment of Myelodysplastic Syndrome September 15, 2020 8:01 AM - StreetInsider Gilead’s Magrolimab, an Investigational Anti-CD47 Monoclonal Antibody, Receives FDA Breakthrough Therapy Designation for Treatment of Myelodysplastic Syndrome September 15, 2020 8:00 AM - BizWire Maxim Group Upgrades Gilead Sciences (GILD) to Buy September 15, 2020 7:43 AM - StreetInsider Tech, healthcare mega deals boost virus-stricken M&A market September 15, 2020 7:06 AM - StreetInsider Gilead Sciences (GILD) PT Lowered to $82 at RBC Capital September 15, 2020 6:19 AM - StreetInsider Tech leads crisis-driven M&A boom with $350 billion deal rush September 14, 2020 12:58 PM - StreetInsider Gilead's shares rise after $21 billion deal for Immunomedics September 14, 2020 11:55 AM - StreetInsider Pre-Open Stock Movers 09/14: (IMMU) (SGMS) (NVDA) Higher; (GILD) (MGM) (WMT) Lower (more...) September 14, 2020 9:30 AM - StreetInsider Form 8-K GILEAD SCIENCES INC For: Sep 13 September 14, 2020 8:02 AM - SEC Filing Gilead Sciences (GILD) Immunomedics (IMMU) Deal a Positive - Jefferies September 14, 2020 7:02 AM - StreetInsider Gilead (GILD) Locks Trodelvy with $21B Immunomedics (IMMU) Deal as Some Question High Price Tag September 14, 2020 6:59 AM - StreetInsider Gilead Sciences (GILD) PT Lowered to $88 at SVB Leerink September 14, 2020 6:55 AM - StreetInsider Gilead Sciences (GILD) call put ratio 3.8 calls to 1 put into acquiring Immunomedics (IMMU) for $21B September 14, 2020 4:00 AM - StreetInsider Gilead Sciences (GILD) to Acquire Immunomedics (IMMU) for $21 Billion September 13, 2020 8:03 PM - StreetInsider Gilead Sciences (GILD) IV into acquiring Immunomedics (IMMU) for $88 per share September 13, 2020 7:33 PM - StreetInsider Gilead Sciences to Acquire Immunomedics September 13, 2020 3:00 PM - BizWire Gilead (GILD) Near Deal to Acquire Immunomedics (IMMU) for More than $20B - WSJ September 12, 2020 3:17 PM - StreetInsider Exclusive: U.S. hospitals turn down remdesivir, limit use to sickest COVID-19 patients September 11, 2020 3:54 PM - StreetInsider UPDATE: Oppenheimer Maintains Gilead Sciences (GILD) at Outperform (Correction) September 10, 2020 7:40 AM - StreetInsider Gilead's(GILD) Kite Submits sBLA to FDA for Yescarta in Relapsed or Refractory Indolent Non-Hodgkin Lymphomas September 4, 2020 8:37 AM - StreetInsider Kite Submits Supplemental Biologics License Application to U.S. Food and Drug Administration for Yescarta® in Relapsed or Refractory Indolent Non-Hodgkin Lymphomas September 4, 2020 8:30 AM - BizWire Gilead Sciences' (GILD) Kite and HiFiBiO Therapeutics Partner to Discover Novel Targets and Antibodies Against Acute Myeloid Leukemia September 3, 2020 8:05 AM - StreetInsider Kite and HiFiBiO Therapeutics Partner to Discover Novel Targets and Antibodies Against Acute Myeloid Leukemia September 3, 2020 8:00 AM - BizWire Gilead Sciences (GILD), Jounce Therapeutics (JNCE) Announce Exclusive License Agreement for Novel Immunotherapy Program September 1, 2020 8:31 AM - StreetInsider Gilead Sciences and Jounce Therapeutics Announce Exclusive License Agreement for Novel Immunotherapy Program September 1, 2020 8:30 AM - Globe NewsWire Gilead Sciences and Jounce Therapeutics Announce Exclusive License Agreement for Novel Immunotherapy Program September 1, 2020 8:30 AM - BizWire FDA expands emergency use of Gilead's remdesivir in hospitalized COVID-19 patients August 28, 2020 6:06 PM - StreetInsider Gilead’s Investigational Antiviral Veklury® (Remdesivir) Receives U.S. Food and Drug Administration Emergency Use Authorization for the Treatment of Patients With Moderate COVID-19 August 28, 2020 4:45 PM - BizWire Gilead Announces Presentation of More Than 40 Abstracts From Extensive Liver Disease Programs at the Digital International Liver Congress™ 2020 August 25, 2020 2:00 AM - BizWire Gilead: FDA could expand remdesivir use despite mixed data August 21, 2020 1:12 PM - StreetInsider Gilead Sciences (GILD) PT Lowered to $67 at Truist Securities August 20, 2020 7:09 AM - StreetInsider Form 4 GILEAD SCIENCES INC For: Aug 15 Filed by: Parsey Merdad August 19, 2020 12:53 PM - SEC Filing Gilead shares slide after FDA knocks back rheumatoid arthritis drug August 19, 2020 9:42 AM - StreetInsider Pre-Open Stock Movers 08/19: (MNTA) (HUD) (IMVT) Higher; (BMRN) (GLPG) (VIPS) Lower (more...) August 19, 2020 9:26 AM - StreetInsider Gilead Sciences (GILD) PT Lowered to $79 at BofA Securities August 19, 2020 8:20 AM - StreetInsider Abbvie (ABBV) A Clear Beneficiary of Gilead's CRL - Mizuho Securities August 19, 2020 7:07 AM - StreetInsider Gilead Sciences (GILD) PT Lowered to $70 at Baird August 19, 2020 6:27 AM - StreetInsider Galapagos (GLPG) announces Gilead (GILD) received CRL for filgotinib for treatment of moderately to severely active rheumatoid arthritis August 19, 2020 6:11 AM - StreetInsider Gilead Sciences (GILD) Receives CRL for Filgotinib for Treatment of Moderately to Severely Active Rheumatoid Arthritis August 19, 2020 6:10 AM - StreetInsider UPDATE: Gilead Sciences (GILD) PT Lowered to $69 at Wells Fargo as CRL Creates Distance From Competition August 19, 2020 5:55 AM - StreetInsider Gilead Sciences (GILD) PT Lowered to $78 at Jefferies August 19, 2020 4:35 AM - StreetInsider Galapagos announces that Gilead received a complete response letter for filgotinib for the treatment of moderately to severely active rheumatoid arthritis August 18, 2020 7:25 PM - StreetInsider Gilead Receives Complete Response Letter for Filgotinib for the Treatment of Moderately to Severely Active Rheumatoid Arthritis August 18, 2020 7:25 PM - BizWire Gilead Sciences (GILD), Tango Therapeutics to Expand Strategic Oncology Collaboration August 17, 2020 4:06 PM - StreetInsider Gilead Sciences and Tango Therapeutics to Expand Strategic Oncology Collaboration August 17, 2020 4:05 PM - BizWire Gilead Sciences (GILD) call put ratio 10.2 calls to 1 put with focus on August 69 calls August 14, 2020 12:44 PM - StreetInsider Form 4 GILEAD SCIENCES INC For: Aug 10 Filed by: Dickinson Andrew D August 12, 2020 4:57 PM - SEC Filing Form 4 GILEAD SCIENCES INC For: Aug 10 Filed by: Wilfong Diane E. August 12, 2020 3:00 PM - SEC Filing Gilead Sciences (GILD) Announces China National Medical Products Administration Approves Truvada for HIV Pre-Exposure Prophylaxis August 11, 2020 8:14 AM - StreetInsider China National Medical Products Administration Approves Truvada® for HIV Pre-Exposure Prophylaxis (PrEP) August 11, 2020 8:11 AM - BizWire Gilead seeks U.S. approval for COVID-19 treatment remdesivir August 10, 2020 11:12 AM - StreetInsider Gilead Sciences (GILD) Submits NDA to U.S. FDA for Veklury (Remdesivir) for Treatment of COVID-19 August 10, 2020 11:00 AM - StreetInsider Gilead Submits New Drug Application to U.S. Food and Drug Administration for Veklury® (Remdesivir) for the Treatment of COVID-19 August 10, 2020 11:00 AM - BizWire Form S-3ASR GILEAD SCIENCES INC August 7, 2020 4:02 PM - SEC Filing Pfizer to make Gilead's COVID-19 treatment remdesivir August 7, 2020 8:11 AM - StreetInsider Pfizer (PFE) Announces Agreement with Gilead (GILD) to Manufacture Remdesivir for Treatment of COVID-19 August 7, 2020 8:00 AM - StreetInsider European stocks end week with gains on telecoms, tech boost August 7, 2020 3:26 AM - StreetInsider Form 10-Q GILEAD SCIENCES INC For: Jun 30 August 6, 2020 4:08 PM - SEC Filing Gilead Sciences (GILD) Announces Update on Veklury (Remdesivir) Manufacturing Network August 6, 2020 3:37 PM - StreetInsider Mylan tightens revenue estimates on COVID-19 pressure; shares fall August 6, 2020 6:46 AM - StreetInsider State attorneys general urge U.S. to let other firms make Gilead COVID-19 drug August 4, 2020 12:20 PM - StreetInsider Rival drugmakers launch joint trial of medicines for COVID-19 August 3, 2020 6:14 AM - StreetInsider Gilead Sciences (GILD) PT Lowered to $87 at RBC Capital July 31, 2020 8:20 AM - StreetInsider Gilead Sciences (GILD) PT Lowered to $79 at Morgan Stanley July 31, 2020 7:44 AM - StreetInsider Gilead Sciences (GILD) PT Raised to $74 at SunTrust July 31, 2020 7:12 AM - StreetInsider Merck to move COVID-19 treatment into large trials, sees sales recovering this year July 31, 2020 6:58 AM - StreetInsider Gilead Sciences (GILD) PT Lowered to $73 at Credit Suisse July 31, 2020 6:08 AM - StreetInsider Form 8-K GILEAD SCIENCES INC For: Jul 30 July 30, 2020 6:58 PM - SEC Filing Gilead Sciences (GILD) Declares $0.68 Quarterly Dividend; 3.8% Yield July 30, 2020 5:21 PM - StreetInsider Gilead raises sales outlook to include COVID-19 treatment remdesivir July 30, 2020 4:30 PM - StreetInsider Gilead Sciences (GILD) Misses Q2 EPS by 34c; Guides In-Line July 30, 2020 4:03 PM - StreetInsider Gilead Sciences Announces Third Quarter 2020 Dividend July 30, 2020 4:02 PM - BizWire Gilead Sciences Announces Second Quarter and First Half 2020 Financial Results July 30, 2020 4:01 PM - BizWire Gilead Sciences (GILD) call put ratio 2.9 calls to 1 put into quarter results July 30, 2020 10:19 AM - StreetInsider Gilead (GILD) Can't Fend Off Antitrust Suit Over HIV Drug Pricing - Bloomberg July 29, 2020 4:36 PM - StreetInsider Gilead Sciences (GILD) weekly IV at 51 into quarter results July 29, 2020 11:14 AM - StreetInsider Gilead Sciences (GILD) Feels Pressure From Reduced HIV and HCV Patient Starts - Piper Sandler July 29, 2020 6:37 AM - StreetInsider EU buys remdesivir to treat 30,000 COVID patients, seeks more July 29, 2020 6:29 AM - StreetInsider European Commission secures EU access to Gilead's (GILD) Remdesivir for treatment of COVID-19 July 29, 2020 6:12 AM - StreetInsider Form 4 GILEAD SCIENCES INC For: Jul 24 Filed by: Mercier Johanna July 28, 2020 6:48 PM - SEC Filing TFF Pharmaceuticals Inc. (TFFP) on Watch on Chatter July 28, 2020 9:45 AM - StreetInsider Gilead Sciences and Satcher Health Leadership Institute at Morehouse School of Medicine Partner to Study Racial Health Inequities Associated with COVID-19 July 28, 2020 9:00 AM - BizWire U.S. drugmaker earnings heat up this week with spotlight on vaccine news July 27, 2020 1:17 PM - StreetInsider Gilead Sciences (GILD) Kite Announced FDA Accelerated Approval of Tecartus to Treat MCL July 24, 2020 1:26 PM - StreetInsider U.S. FDA Approves Kite’s Tecartus™, the First and Only CAR T Treatment for Relapsed or Refractory Mantle Cell Lymphoma July 24, 2020 1:25 PM - BizWire GILEAD  AND  GALAPAGOS  ANNOUNCE  POSITIVE  EUROPEAN  CHMP  OPINION  FOR  JYSELECA®  (FILGOTINIB)  FOR  THE  TREATMENT  OF  ADULTS  WITH  MODERATE  TO  SEVERE  RHEUMATOID  ARTHRI July 24, 2020 8:15 AM - StreetInsider Gilead Sciences (GILD), Galapagos (GLPG) Announce Positive European CHMP Opinion for Jyseleca for Treatment of Adults With Moderate to Severe Rheumatoid Arthritis July 24, 2020 8:13 AM - StreetInsider Gilead and Galapagos Announce Positive European CHMP Opinion for Jyseleca® (Filgotinib) for the Treatment of Adults With Moderate to Severe Rheumatoid Arthritis July 24, 2020 8:10 AM - BizWire Trump says virus will probably get worse before it gets better July 21, 2020 5:13 PM - StreetInsider Gilead Sciences (GILD) Acquires 49.9% Stake in Tizona Therapeutics for $300M, With Option to Acquire Remainder July 21, 2020 8:31 AM - StreetInsider Gilead Sciences Secures Exclusive Option to Acquire Tizona Therapeutics for $300 Million July 21, 2020 8:30 AM - BizWire Gilead Sciences (GILD) Consensus Looks High, PT Remains $97 at Jefferies July 21, 2020 6:42 AM - StreetInsider UPDATE: Credit Suisse Upgrades Gilead Sciences (GILD) to Neutral July 20, 2020 6:54 AM - StreetInsider Gilead Sciences to Release Second Quarter 2020 Financial Results on Thursday, July 30, 2020 July 16, 2020 4:01 PM - BizWire Gilead Sciences (GILD) PT Raised to $80 at Morgan Stanley July 15, 2020 8:59 AM - StreetInsider Gilead Sciences (GILD) IV into Moderna (MRNA) IV into disclosing COVID-19 vaccine data July 15, 2020 4:39 AM - StreetInsider Gilead Sciences (GILD) call put ratio 4.9 calls to 1 put on tight 4-year range July 14, 2020 2:29 PM - StreetInsider Gilead Sciences and Arcus Biosciences Complete Closing of Their 10-Year Partnership to Co-Develop and Co-Commercialize Next-Generation Cancer Immunotherapies July 13, 2020 4:05 PM - BizWire Pre-Open Stock Movers 07/10: (WIMI) (MATX) (SPAQ) Higher; (ZIOP) (FC) (WDFC) Lower (more...) July 10, 2020 9:26 AM - StreetInsider Gilead Sciences (GILD) Set to Open Up 2.7% Following Remdesivir Data July 10, 2020 9:08 AM - StreetInsider Gilead analysis shows remdesivir reduced coronavirus death risk, more studies needed July 10, 2020 8:56 AM - StreetInsider Gilead Sciences (GILD) Presents Additional Data on Remdesivir for Treatment of COVID-19 July 10, 2020 8:31 AM - StreetInsider Gilead Presents Additional Data on Investigational Antiviral Remdesivir for the Treatment of COVID-19 July 10, 2020 8:30 AM - BizWire Wall Street jumps with financials; Gilead data offsets virus fears July 10, 2020 6:53 AM - StreetInsider U.S. dollar slides as vaccine news offsets surge in virus cases July 9, 2020 8:58 PM - StreetInsider Gilead to deliver more remdesivir to Europe from autumn: WiWo July 9, 2020 4:00 AM - StreetInsider Gilead Sciences (GILD) Statement on the Initiation of Clinical Testing of an Inhaled Solution of Remdesivir for Potential Outpatient Treatment of COVID-19 July 8, 2020 2:30 PM - StreetInsider Exclusive: EU secures potential COVID-19 drugs from Roche, Germany's Merck July 8, 2020 6:04 AM - StreetInsider Gilead Sciences Presents Survey Findings on PrEP Access and Utilization in the U.S. During COVID-19 Shelter-in-Place Orders July 8, 2020 4:01 AM - BizWire GSK to develop plant-based COVID-19 vaccine with Canada's Medicago July 7, 2020 8:59 AM - StreetInsider Gilead Sciences (GILD) Remdesivir Investment Likely to Break Even in 3Q - SunTrust July 6, 2020 7:44 AM - StreetInsider Gilead Sciences (GILD) Lenacapavir Data Supports Ongoing Ph2 & 3 Studies- RBC Capital July 6, 2020 6:05 AM - StreetInsider Mylan (MYL) Granted Regulatory Approval for Remdesivir Lyophilized Powder for Injection 100 mg/vial in India for Restricted Emergency Use in COVID-19 Patients July 6, 2020 6:02 AM - StreetInsider Gilead Sciences Presents Data Supporting a Potential Six-Month Dosing Interval for Investigational HIV-1 Capsid Inhibitor Lenacapavir (GS-6207) July 4, 2020 3:01 AM - BizWire New Findings on Gilead’s Biktarvy® Presented at AIDS 2020: Virtual Include Positive Switch Data in Older Adults July 4, 2020 3:01 AM - BizWire European Commission Grants Conditional Marketing Authorization for Gilead’s Veklury® (remdesivir) for the Treatment of COVID-19 July 3, 2020 7:56 AM - BizWire Gilead's COVID-19 antiviral remdesivir gets conditional EU clearance July 3, 2020 7:52 AM - StreetInsider Full Article List